Influenza Antigen Challenge Kit from Canada
Live attenuated influenza antigens for nasal challenge in immunity diagnostic studies. Classified in HTS 3006.30.10.00 as diagnostic reagents containing viral antigens administered directly to patients. Used in clinical trials for vaccine efficacy testing.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Select agent registration if H5N1 strains; FDA IND for trial use
• BSL-2 lab certification for handling; include challenge protocol
• Label clearly for 'clinical trial diagnostic use' to stay in 3006